DME Capital Management David Einhorn
New York, NY 21 processed 13Fs on this site, 2021 Q3 to 2026 Q3
- $3.6B
- 45 holdings
- 2026 Q3
- −9.1% QoQ
- Top 5 37.4%
AUM over time
Book
| GRBK, Green Brick Partners | Reduce −8.2% | 10,467,383 | $60.23 | $630M | −937,500 | +$38M | |
| BHF, Brighthouse Financial | Reduce −0.7% | 3,021,763 | $51.54 | $156M | −21,860 | −$5.3M | |
| KD, Kyndryl | Add +3.9% | 6,605,059 | $21.76 | $144M | +248,990 | +$12M | |
| CEIX, Consol Energy | Reduce −22.1% | 1,640,750 | $83.76 | $137M | −464,827 | −$74M | |
| ALIT, Alight | Add +24.7% | 11,527,930 | $9.85 | $114M | +2,286,260 | +$35M | |
| THC, Tenet Healthcare | Reduce −32.3% | 890,630 | $105.11 | $94M | −425,340 | −$5.8M | |
| ODP | Reduce −2.1% | 1,710,580 | $53.05 | $91M | −37,520 | −$7.7M | |
| PENN, Penn Entertainment | New | 4,554,710 | $18.21 | $83M | +4,554,710 | +$83M | |
| LIVN, Livanova | Add +8.4% | 1,332,804 | $55.94 | $75M | +103,488 | +$11M | |
| TECK, Teck Resources | Hold | 1,552,063 | $45.78 | $71M | — | — | |
| VTRS, Viatris | Add +34.6% | 4,517,620 | $11.94 | $54M | +1,161,850 | +$18M | |
| PKG, Graphic Packaging | Reduce −29.2% | 1,796,130 | $29.18 | $52M | −739,970 | −$10M | |
| GLD, SPDR Gold Shares | Reduce −36.3% | 246,671 | $205.72 | $51M | −140,273 | −$23M | |
| HPQ, HP | New | 1,615,960 | $30.22 | $49M | +1,615,960 | +$49M | |
| DHT, DHT Holdings | Add +6.5% | 4,024,340 | $11.50 | $46M | +244,460 | +$9.2M | |
| ROIV, Roivant Sciences | New | 4,190,490 | $10.54 | $44M | +4,190,490 | +$44M | |
| FCNCA, First Citizens Bancshares | Add +1.4% | 25,160 | $1,635 | $41M | +340 | +$5.9M | |
| WFRD, Weatherford International | Reduce −30.5% | 317,477 | $115.42 | $37M | −139,128 | −$8M | |
| LBTYA, Liberty Global | New | 2,041,580 | $16.92 | $35M | +2,041,580 | +$35M | |
| SDRL, Seadrill 2021 | Add +4.7% | 569,405 | $50.30 | $29M | +25,470 | +$2.9M | |
| AER, Aercap | Add +27.6% | 319,050 | $86.91 | $28M | +69,050 | +$9.1M | |
| NPWR, Net Power | Reduce −34.5% | 1,959,280 | $11.39 | $22M | −1,032,830 | −$7.9M | |
| RSP | Reduce −1.6% | 182,511 | $101.57 | $19M | −3,010 | +$1.4M | |
| XAR, SPDR Ser Trust | Reduce −1.6% | 127,557 | $140.51 | $18M | −2,110 | +$364K | |
| KVUE, Kenvue | Add +27.6% | 707,740 | $21.46 | $15M | +153,250 | +$3.3M | |
| COYA, Coya Therapeutics | Hold | 1,274,026 | $9.92 | $13M | — | — | |
| GPRO, Gopro | Hold | 2,823,100 | $2.23 | $6.3M | — | — | |
| LKFT, Galapagos | Reduce −1.7% | 159,828 | $32.20 | $5.1M | −2,750 | −$1.5M | |
| TEVA, Teva Pharmaceutical Industries | Add +21.0% | 324,850 | $14.11 | $4.6M | +56,380 | +$1.8M | |
| OIH, Vaneck ETF Trust | Add +21.0% | 11,220 | $336.33 | $3.8M | +1,950 | +$904K | |
| SHC, Sotera Health | Reduce −10.9% | 300,110 | $12.01 | $3.6M | −36,860 | −$2.1M | |
| GDX, Vaneck ETF Trust | New | 111,390 | $31.62 | $3.5M | +111,390 | +$3.5M | |
| Danimer Scientific | Hold | 2,734,580 | $1.09 | $3M | — | — | |
| GANX, Gain Therapeutics | Reduce −3.8% | 566,130 | $3.77 | $2.1M | −22,280 | +$213K | |
| CLVT, Clarivate | New | 279,560 | $7.43 | $2.1M | +279,560 | +$2.1M | |
| FCG, First Trust Exchange-Traded Fund | Add +21.0% | 70,830 | $27.44 | $1.9M | +12,290 | +$522K | |
| IVZ, Invesco Actvely Mngd Etc Fund | Add +21.0% | 117,360 | $13.87 | $1.6M | +20,370 | +$338K | |
| TLIS, Talis Biomedical | Hold | 149,052 | $8.75 | $1.3M | — | — | |
| NUVB, Nuvation Bio | Hold | 34,995 | $3.64 | $127K | — | — | |
| NBSE, Neubase Therapeutics | Hold | 136,350 | $0.4499 | $61K | — | — |
Exits / last held
Gone since 2023 Q4, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| GPOR, Gulfport Energy | Exit | 0 | $133.20 | $30M | −222,970 | −$30M | |
| HRI, Herc | Exit | 0 | $148.89 | $20M | −135,610 | −$20M | |
| FHN, First Horizon | Exit | 0 | $14.16 | $20M | −1,377,090 | −$20M | |
| NYCB, New York Community Bancorp | Exit | 0 | $10.23 | $19M | −1,828,730 | −$19M |
Filings history
21 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q3 | 45 | $3.6B | −9.1% | 13F-HR | 11/16/2026 | 000117266126005372 |
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
21 processed 13Fs on this site, 2021 Q3 to 2026 Q3
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- The Essays of Warren Buffett, 8th Ed., Warren Buffett, Lawrence A. Cunningham View on Amazon
- One Up On Wall Street (Lynch), Peter Lynch View on Amazon